Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

2013 ACR/ARHP Annual Meeting: Advances in Genomic Research Demystify, Defeat Disease

Susan Bernstein  |  Issue: December 2013  |  December 1, 2013

To ensure that future scientists viewing a synthetic bacterium will not confuse it for something naturally occurring, Dr. Venter and his team created a microscopic watermark. Marks included the institute’s URL, the names of the scientists involved in the project, and three inspiring quotes. Including a quote from the Irish writer James Joyce required copyright permission from his estate, and another saying from American physicist Richard Feynman was originally misquoted. The correct Feynman quote imprinted on the synthetic bacterium encapsulates the spirit of discovery in genomic research: “What I cannot create, I do not understand,” said Dr. Venter.

Future genomic research must target the 50 or so genes whose exact functions are still unknown, said Dr. Venter. One potential application of genomic research is creating synthetic DNA that can correct disease-causing errors in cells, and then transplanting those engineered cells back into the body, he noted.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another potential application is in the area of vaccine development, Dr. Venter said. Currently, vaccines for deadly viruses, like influenza, must be manufactured and then shipped to vaccination sites worldwide. Instead, researchers at the Venter Institute are sequencing new, emerging flu viruses so vaccinations could be created closer to where they are needed, something Dr. Venter calls “biological teleportation.” To respond to a global flu pandemic, “we could send a new vaccine around the world in seconds,” he said. “Our ultimate solution is a digital, biological converter attached to your computer.”


Susan Bernstein is a writer based in Atlanta.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:Meeting Reports Tagged with:2013 ACR/ARHP Annual MeetingACR/ARHPbacteriagenomic research

Related Articles

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Experts Discuss the Latest Precision Medicine Research

    February 18, 2018

    SAN DIEGO—In just two decades, precision medicine has gone from futuristic concept to realistic toolbox for clinical physicians. At the 2017 ACR Clinical Research Conference on Nov. 3, the Precision Medicine in Rheumatic Diseases: Hopes and Challenges lecture featured rheumatologists and experts on genetics, genomics, pharmaco­genetics and big data who spoke about the latest research…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting

    March 1, 2014

    New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences